U.S., April 30 -- An application to own the trademark for 'LUPELIC' has been filed on Jan. 13, 2025.
Owner(s):
Glaxo Group Limited; Gunnels Wood Road, GSK Medicines Research Centre, UNITED KINGDOM
Goods and/or Services:
For: Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system relate...